Why quick fixes fall short - and what nutrition can do instead.
Today, The Age highlighted a compelling trend in the world of weight-loss medications: while GLP-1 drugs like semaglutide (popularised by headlines and hype) can help people lose weight, many of the benefits fade once the medication stops. In fact, a study led by Oxford University researchers and published in the British Medical Journey has found that people who cease use of GLP-1 agonist medications experience a weight gain relapse of 400g per month, and all weight lost is likely to be regained in less than two years¹.
This isn’t just a scientific nuance - it’s part of a broader cultural conversation about how we approach weight and wellbeing.
One example resonating with audiences globally is the recent Netflix docuseries Fit For TV: The Reality Of The Biggest Loser. Time and time again, contestants achieved dramatic weight loss in a short period - only to regain much of it (and in some cases, more weight) once the intense intervention ended. This pattern speaks to a simple truth: rapid fixes often produce rapid rebounds when long-term habits and metabolic support are missing.
So, while medications and dramatic regimes can deliver quick results, they often don’t address the underlying systems that govern appetite, metabolism and daily energy balance.
Why Weight-Loss Drugs Aren’t Enough on Their Own
Emerging guidance from global health authorities points out that medications such as GLP-1 agonists are tools - not cures. They work in conjunction with lifestyle and dietary changes, rather than replacing them². In Australia, experts emphasise that pharmaceutical approaches to obesity should be paired with dietetic support and ongoing nutrition care to protect overall health².
This is important because even if drugs suppress appetite temporarily, when you stop using GLP-1 agonists, your physiology will return to its prior state, including appetite signals and metabolic patterns.
Meanwhile, many Australians struggle with a separate but closely related challenge: insufficient fibre intake. More than 80% of adults do not meet recommended daily fibre targets, and this has real consequences for digestive and metabolic wellbeing³.
Fibre, the Gut, and Metabolic Health
Unlike quick fixes, everyday nutrition - especially prebiotic and fermentable fibre - works with the body’s existing systems.
Dietary fibre that reaches the large intestine feeds beneficial microbes, which produce short-chain fatty acids (SCFAs). These SCFAs play roles in:
- Appetite regulation
- Metabolic signalling
- Gut barrier integrity
- Inflammation modulation⁴
There is strong evidence showing that higher-fibre diets are associated with improved weight stability, reduced disease risk, and enhanced gut health⁵.
Australian researchers are increasingly recognising the importance of fibre diversity - different types of fibre influence the microbiome and metabolism in unique ways, far beyond what an appetite suppressant alone can do⁶.
Nutrition First, Long-Term Health Second
Food-based strategies alone won’t replace medical care for everyone - but they can be part of a sustainable foundation for health. Nutrition research shows that diets rich in fermentable and prebiotic fibres can improve gut microbial markers linked to metabolic health without the side effects associated with many medications⁷.
Rather than positioning nutrition and pharmaceuticals as opposites, it’s more accurate to see them as complementary tools. Daily habits that support gut ecology can help stabilise appetite, support digestion and contribute to metabolic resilience - foundations that allow drug-based therapies to be more effective and sustainable when they’re medically appropriate.
How BARLEYMAX® Super Barley Supports a Food-First Approach
BARLEYMAX® Super Barley is a wholegrain developed by CSIRO with a unique prebiotic fibre profile. It has been shown in clinical research to:
- Enhance beneficial gut bacteria
- Support the production of SCFAs
- Improve markers associated with healthier gut fermentation⁷
By simple daily use - such as starting the day with BARLEYMAX® Super Barley in breakfast or incorporating it into snacks and meals - people can meaningfully increase their fibre intake in a way that fits normal life and supports long-term gut health.
A Balanced Path Forward
The stories from The Biggest Loser, the headlines around weight-loss drugs, and the lived experience of many Australians point to the same conclusion:
Quick fixes don’t build lasting wellbeing.
Medications can have an important role in clinical care, but sustainable health is built through everyday habits — especially through nourishing, diverse, high-fibre foods that support the gut and metabolism from the inside out.
References
-
The Age. “Game-changing weight-loss drugs need to be taken for life or health benefits are lost.” 2026.
- World Health Organization GLP-1 guideline: obesity care should include diet and lifestyle support alongside medication. (WHO, 2025).
- Fayet-Moore F et al. Nutrients. 2018;10(7):799.
- Topping DL & Clifton PM. Physiol Rev. 2001;81(3):1031–1064.
- Reynolds et al. Lancet. 2019;393(10170):653-66.
- Australian prebiotic research: calls for fibre diversity in dietary guidelines (2025 review).
- Clinical studies showing BARLEYMAX® enhances beneficial gut microbes (multiple trials, 2010–2025).
